Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 8 M10 M9 M6 M8 M 33 M Research & development ————— — Operating income -255 M-430.3 M-258 M-336 M-377 M -1.4 B Non-Operating Income, Total -256 M-425 M-258 M-326 M-373 M -1.38 B Interest expense, net of interest capitalized 226 M250 M232 M220 M210 M 912 M Non-Operating Income, excl. Interest Expenses -482 M-675 M-490 M-546 M-583 M -2.29 B Unusual income/expense ————— — Pretax income -624 M-983.3 M-632 M-776 M-305 M -2.7 B Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 120 M-209 M214 M-114 M-441 M -550 M Discontinued operations ————— — Net income 120 M-209 M214 M-114 M-441 M -550 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 120 M-209 M214 M-114 M-441 M -550 M Basic earnings per share (Basic EPS) 0.43-0.750.76-0.41-1.57 -1.97 Diluted earnings per share (Diluted EPS) 0.43-0.750.76-0.41-1.57 -1.97 Average basic shares outstanding 280.07 M280.07 M280.07 M280.07 M280.07 M — Diluted shares outstanding 280.07 M280.07 M280.07 M280.07 M280.07 M — EBITDA -284 M-563.3 M-379 M-444 M-482 M -1.87 B EBIT -368 M-555.3 M-374 M-446 M-482 M -1.86 B Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) -4 M-8 M-5 M2 M0 -11 M